Cara Therapeutics (CARA) P/S US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 191.2 | 965.7 | 13.8 | 1.92 | 117.4 | 19 427 | ||
| Changes by years, y/y, % | +453% | +405% | -99% | -86% | +6 021% | +27.7% | |||
Cara Therapeutics. P/S
Cara Therapeutics. P/S, changes, %
Cara Therapeutics (CARA) P/S US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/S | ? | 30.6 | 0.00 | 0.00 | 0.00 | 0.00 | 19 427 | |
| Changes by years, y/y, % | +944% | -100% | -100% | -100% | -100% | |||
| Changes by quarters, q/q, % | -78% | -100% | ||||||